The AI IPO Wave Is Here. You Can’t Buy Anthropic Yet — But You Can Play It Right Now.
Two trillion-dollar AI listings filed in a single week. Here’s how bargain hunters position before the crowd catches up.
AI Needs a Lot of Electricity. The Grid Can’t Keep Up. Here’s Where the Money Is Going.
The power bottleneck is the most underpriced constraint in the AI buildout — and utilities are finally getting noticed.
NVDA’s $81.6B Quarter and the Options Setup That Followed
Record earnings, a 25x dividend hike, and elevated IV – here’s what the tape is saying right now
Micron Is Coiling Into June 24 Earnings — Watch These Levels
MU has surged over 200% YTD, Wolfe Research just raised its target to $1,250, and Q3 fiscal 2026 earnings drop June 24. The AI memory trade is at a critical inflection.
The AI Infrastructure Stock Jensen Huang Just Put on Every Radar
Marvell Technology (MRVL) may be the most important chip company most investors still haven’t fully priced.
SpaceX Just Went Public. The Largest IPO in History Lands Today — and the Options Implications Are Enormous.
SPCX debuts on Nasdaq at $135, valued at $1.75 trillion. Here’s how traders are thinking about positioning around the most consequential new listing in a generation.
GSK Just Paid $10.6 Billion for This Precision Oncology Bet — Here’s What It Signals
The Nuvalent acquisition is the biggest biopharma deal of the week — and it’s rewriting the playbook for lung cancer investing.
ORCL Reports Tonight. The Options Market Is Already Pricing a 13% Move.
Oracle’s Q4 earnings hit after close — and the derivatives market is positioning for a major swing in either direction.
The Chip Nobody Talked About — Until Jensen Huang Said Four Words
Marvell Technology is no longer flying under the radar, and the case for owning it goes well beyond one speech.
CrowdStrike Just Split Its Stock. Here’s What the Valuation Debate Is Really About.
The cybersecurity leader crossed $5 billion in ARR and announced a 4-for-1 stock split. The post-earnings selloff may be the setup.